Lab Denboba

Group Leader Ayele Argaw-Denboba

Ayele Argaw-Denboba studied at the University of Addis Ababa in Ethiopia. He completed his Ph.D. at the University of Rome "Tor Vergata" in Italy with a project investigating the role of retrotransposons in cancer progression.

From 2015, he was a postdoctoral research associate at the University of Rome "Tor Vergata" and then became a Fellow in the international flagship postdoctoral program EI3POD at the European Molecular Biology Laboratory (EMBL) in Rome, Italy, in collaboration with EMBL Heidelberg, Germany. His postdoctoral research focused on gut microbiota-germline interactions.

Since August 2023, Ayele Argaw-Denboba leads the research group “Microbiome-Epigenome Axis in Early Life Programming” at the MPI of Immunobiology and Epigenetics in Freiburg (MPI-IE), Germany.

Qualifications and history

  • Born in Ethiopia. Undergraduate studies in clinical laboratory science, and tropical & infectious disease at Addis Ababa University, Ethiopia.
  • 2012-2014 PhD studies at the University of Rome ‘Tor Vergata’, Italy
  • 2015-2017 Postdoctoral research associate at the University of Rome ‘Tor Vergata’, Italy
  • 2018-2023 EIPOD postdoctoral Fellow co-funded by European Molecular Biology Laboratory (EMBL) and European Union’s Horizon 2020 research and innovation programme under Marie Skłodowska Curie Actions
  • Since 2023 Group Leader at the Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany


+49 (0) 761 5108-
Daum, Noel
PhD Student
  • 551
Denboba, Ayele Argaw
  • 550
Kim, Kyungwoo
PhD Student
  • 551, 714
Go to Editor View